24 May 2013
Keywords: cogentus, initiates, ph, iii, cgt-2168, trial, usa
Article | 28 January 2008
The USA's Cogentus Pharmaceuticals has enrolled the first patient in a pivotal Phase III study of its novel combination medicine ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
28 January 2008
23 May 2013
© 2013 thepharmaletter.com